Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin-1

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 9, 2002, Pages 1064-1069

  Moller S ^a   Gulberg V ^a   Becker, U ^a   Gerbes, A L ^a   Henriksen, Jens H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Arterial compliance; Circulatory dysfunction; Cirrhosis; Endothelin 1; Endothelin 3; Vasoconstrictors

Indexed keywords

ENDOTHELIN 1; OCTREOTIDE;

ADULT; AGED; ARTERIAL BLOOD; ARTERY COMPLIANCE; ARTERY CONSTRICTION; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INFUSION; FEMALE; HEMODYNAMIC MONITORING; HORMONE ACTION; HUMAN; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; SYSTEMIC CIRCULATION;

ADULT; AGED; ARTERIES; ENDOTHELIN-1; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OCTREOTIDE; VASOCONSTRICTOR AGENTS;

EID: 18644362095     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202320378275     Document Type: Article

References (29)

1. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laënnecs cirrhosis. J Clin Invest 1953;32:1025-33.
2. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later. Pathophysiology and clinical consequences. Hepatology 1994;20:1359-63.
3. Møller S, Henriksen JH. Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of cirrhotic cardiomyopathy. Scand J Gastroenterol 2001;36:785-94.
4. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index. Am J Physiol Gastrontest Liver Physiol 2001;280:G584-94.
5. Henriksen JH, Møller S, Schifter S, Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J Hepatol 1999;31:712-18.
6. Henriksen JH, Møller S, Schifter S, Abrahamsen J. Becker U. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems. Gut 2001;49:112-18.
7. Møller S, Gulberg V, Henriksen JH, Gerbes AL. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics. J Hepatol 1995;23:135-44.
8. Gerbes AL, Møller S, Gulberg V, Henriksen JH. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 1995;21:735-9.
9. Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D, et al. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype I. Gastroenterology 2001;121:915-30
10. Møller S, Brinch K, Henriksen JH, Becker U. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1997;26:1026-33.
11. Henriksen JH, Ring-Larsen H, Kanstrup I-L, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis: evidence of enhanced sympathetic nervous activity in patients with cirrhosis. Gut 1984;25:1034-43.
12. Møller S, Becker U, Schifter S, Abrahamsen J, Henriksen JH. Effect of oxygen inhalation on systemic, central and splanchnic haemodynamics in cirrhosis. J Hepatol 1996;25:316-28.
13. Møller S, Winberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995;22:88-95.
14. Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989;97:1506-13.
15. Gülberg V, Gerbes AL, Vollmar AM, Paumgartner G. Endothelin-3 like immunoreactivity in plasma of patients with cirrhosis of the liver. Life Sci 1992;51:1165-9.
16. Stergiopulos N, Meister JJ, Westerhof N. Evaluation of methods for estimation of total arterial compliance. Am J Physiol 1985;268:H1540-8.
17. Karakawa M, Igarashi K. A mathematical approach to cardiovascular disease. Mechanics of blood circulation. Tokyo: Kokuseido Publishing; 1998. p. 1-40.
18. Defares JG, Wise ME. Theory of the measurement of arterial compliance in humans. Bull Math Biol 1973;35:237-44.
19. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral artery vasodilation hypothesis. A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;5:1151-7.
20. Arroyo V, Gines P. Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis. Gastroenterology 1992;102:1077-9.
21. La M, Reid JJ. Endothelin-1 and the regulation of vascular tone. Clin Exp Pharmacol Physiol 1995;2:315-23.
22. Helmy A, Jalan R, Newby DE, Johnston NR, Hayes PC, Webb DJ. Altered peripheral vascular responses to exogenous and endogenous endothelin in patients with well-compensated cirrhosis. Hepatology 2001;33:826-31.
23. Trevisani F, Colantoni A, Gerbes AL, Gulberg V, Sica G, Caraceni P, et al. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relations with the arterial pressure and renal function. J Hepatol 1997;26:808-15.
24. Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 2001;89:273-93.
25. Stefanadis C, Dernellis J, Tsiamis E, Stratos C, Diamantopoulos L, Michaelides A, et al. Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease. Eur Heart 2000;21:390-6.
26. De Simone G, Roman MJ, Daniels SR, Mureddue G, Kimball TR, Greco R, et al. Age-related changes in total arterial capacitance from birth to maturity in a normotensive population. Hypertension 1997;29:1213-17.
27. Møller S, Bendtsen F, Henriksen JH. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis. Scand J Gastroenterol 2001;36:653-7.
28. Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol 2000;95:199-203.
29. Ludwig D, Schadel S, Bruning A, Schiefter B, Stange EF. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study. Dig Dis Sci 2000;45:1019-27.